BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 38510852)

  • 1. Salivary and Serum Interleukin-6: A Credible Marker for Predicting Oral Leukoplakia and Oral Squamous Cell Carcinoma by Enzyme-Linked Immunosorbent Assay (ELISA).
    Oshin M; Kulkarni PG; D SPR; Deepthi G; S KS; S JK
    Cureus; 2024 Apr; 16(4):e59113. PubMed ID: 38803729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of salivary levels of S100A7 in oral submucous fibrosis and oral leukoplakia.
    Fathima R; Ramamoorthi R; Gopalakrishnan S; Jayaseelan VP; Muniapillai S
    J Oral Maxillofac Pathol; 2024; 28(1):84-89. PubMed ID: 38800445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD44 and SALL4 in Leukoplakia and Oral Squamous Cell Carcinoma.
    Sahoo P; Kumar H; Panda A; Dash KC; Bhuyian L; Raghuvanshi M; Panda B
    J Pharm Bioallied Sci; 2024 Apr; 16(Suppl 2):S1761-S1763. PubMed ID: 38882798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of oral cancer and oral potentially malignant disorders using artificial intelligence-based image analysis.
    Kouketsu A; Doi C; Tanaka H; Araki T; Nakayama R; Toyooka T; Hiyama S; Iikubo M; Osaka K; Sasaki K; Nagai H; Sugiura T; Yamauchi K; Kuroda K; Yanagisawa Y; Miyashita H; Kajita T; Iwama R; Kurobane T; Takahashi T
    Head Neck; 2024 Jun; ():. PubMed ID: 38860703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilizing deep learning for automated detection of oral lesions: A multicenter study.
    Ye YJ; Han Y; Liu Y; Guo ZL; Huang MW
    Oral Oncol; 2024 Jun; 155():106873. PubMed ID: 38833826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization test: A prognostic biomarker in oral potentially malignant disorders and oral cancer.
    Joshi K; Shah J
    Indian J Pathol Microbiol; 2024 Jun; ():. PubMed ID: 38847217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of silver binding nucleolar organizer regions (AgNORs) in proliferative lesions of bronchi, colon and thyroid--semiautomatic computer image analysis].
    Zaczek M
    Folia Med Cracov; 1996; 37(1-2):67-88. PubMed ID: 9312528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-Assisted Morphometric Comparative Analysis of Argyrophilic Nucleolar Organizer Regions (AgNORs) in Leukoplakia With Dysplasia and Oral Squamous Cell Carcinoma.
    Nararyanan RC; Sebastian BT; Sulaikha SH; Augustine C; Thomas T; Sudhakaran A
    Cureus; 2024 Feb; 16(2):e54471. PubMed ID: 38510852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and qualitative assessment of argyrophilic nucleolar organizer regions in normal, premalignant and malignant oral lesions.
    Khushbu BP; Chalishazar M; Kale H; Baranwal M; Modi T
    J Oral Maxillofac Pathol; 2017; 21(3):360-366. PubMed ID: 29391709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy of AgNOR as a proliferative marker in oral leukoplakia: A morphometric analysis.
    Garg KN; Raj V; Chandra S
    Natl J Maxillofac Surg; 2013 Jan; 4(1):40-5. PubMed ID: 24163551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphometric analysis of argyrophilic nucleolar organizer regions (AgNORs) in nasopharyngeal carcinoma.
    Pak MW; To KF; Chen MH; Lo SY; Lam PK; van Hasselt CA
    Head Neck; 2000 Dec; 22(8):760-4. PubMed ID: 11084635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
    Chen M; Lee JC; Lo S; Shen J
    Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparative Study of Morphometric Analysis of Nucleolar Organizer Regions in Oral Leukoplakia and Oral Squamous Cell Carcinoma and Significance of AgNOR as a Diagnostic Tool.
    Singh A; Singh S; Soni V; Srivastava DK
    Cureus; 2023 Aug; 15(8):e44228. PubMed ID: 37772250
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.